GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Healthlead PCL (BKK:HL) » Definitions » ROIC %

Healthlead PCL (BKK:HL) ROIC % : 19.85% (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Healthlead PCL ROIC %?

ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. Healthlead PCL's annualized return on invested capital (ROIC %) for the quarter that ended in Dec. 2023 was 19.85%.

As of today (2024-05-22), Healthlead PCL's WACC % is 10.03%. Healthlead PCL's ROIC % is 14.34% (calculated using TTM income statement data). Healthlead PCL generates higher returns on investment than it costs the company to raise the capital needed for that investment. It is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases.


Healthlead PCL ROIC % Historical Data

The historical data trend for Healthlead PCL's ROIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Healthlead PCL ROIC % Chart

Healthlead PCL Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
ROIC %
16.40 27.41 30.18 32.51 14.27

Healthlead PCL Quarterly Data
Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
ROIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 31.72 11.61 12.92 12.14 19.85

Competitive Comparison of Healthlead PCL's ROIC %

For the Medical Distribution subindustry, Healthlead PCL's ROIC %, along with its competitors' market caps and ROIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Healthlead PCL's ROIC % Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Healthlead PCL's ROIC % distribution charts can be found below:

* The bar in red indicates where Healthlead PCL's ROIC % falls into.



Healthlead PCL ROIC % Calculation

Healthlead PCL's annualized Return on Invested Capital (ROIC %) for the fiscal year that ended in Dec. 2023 is calculated as:

ROIC % (A: Dec. 2023 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (A: Dec. 2022 ) + Invested Capital (A: Dec. 2023 ))/ count )
=100.721 * ( 1 - 20.58% )/( (469.063 + 651.873)/ 2 )
=79.9926182/560.468
=14.27 %

where

Invested Capital(A: Dec. 2022 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1288.185 - 165.803 - ( 653.319 - max(0, 187.096 - 890.347+653.319))
=469.063

Invested Capital(A: Dec. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1382.345 - 172.595 - ( 557.877 - max(0, 199.257 - 847.954+557.877))
=651.873

Healthlead PCL's annualized Return on Invested Capital (ROIC %) for the quarter that ended in Dec. 2023 is calculated as:

ROIC % (Q: Dec. 2023 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Sep. 2023 ) + Invested Capital (Q: Dec. 2023 ))/ count )
=154.364 * ( 1 - 20.32% )/( (587.585 + 651.873)/ 2 )
=122.9972352/619.729
=19.85 %

where

Invested Capital(Q: Sep. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1300.92 - 148.897 - ( 564.438 - max(0, 172.366 - 830.383+564.438))
=587.585

Invested Capital(Q: Dec. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1382.345 - 172.595 - ( 557.877 - max(0, 199.257 - 847.954+557.877))
=651.873

Note: The Operating Income data used here is four times the quarterly (Dec. 2023) data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Healthlead PCL  (BKK:HL) ROIC % Explanation

ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROIC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, Healthlead PCL's WACC % is 10.03%. Healthlead PCL's ROIC % is 14.34% (calculated using TTM income statement data). Healthlead PCL generates higher returns on investment than it costs the company to raise the capital needed for that investment. It is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases. Healthlead PCL earns returns that do not match up to its cost of capital. It will destroy value as it grows.


Be Aware

Like ROE % and ROA %, ROIC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.


Healthlead PCL ROIC % Related Terms

Thank you for viewing the detailed overview of Healthlead PCL's ROIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Healthlead PCL (BKK:HL) Business Description

Traded in Other Exchanges
N/A
Address
99/4 Moo 10, Bang Muang Sub-District, Bang-Yai District, Nonthaburi, THA, 11140
Healthlead PCL is engaged in the business of healthcare-related and medical products. It operates in the pharmacy business, distribution of medical supplies, cosmeceuticals, and dietary supplements. medical equipment and various health products. as well as in business regarding invention business, developing, importing, and distributing innovative healthcare products.